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V. Curci1 and A. Morabito71Diabetology Centre, Diabetic Foot Centre, Policlinico Multimedica, Sesto S. Giovanni, Milano, 2Diabetic Foot
Unit, Abano Terme Hospital, Abano Terme, Padova, 3Interventional Radiology Laboratory, Policlinico
Multimedica, Sesto S. Giovanni, Milano, 4Cardiovascular Catheterization Laboratory, Citta` di Brescia
Hospital, Brescia, 5Vascular Surgery, University of Milan, Milano, 6Vascular Surgery, University of Bologna,
Bologna, and 7Medical Statistics Unit, University of Milan, Milano, ItalyObjective. To evaluate the effectiveness of peripheral angioplasty (PTA) as the first-choice revascularisation procedure in
diabetic patients with critical limb ischemia (CLI).
Design. Prospective study.
Methods. PTAwas employed as first choice revascularisation in a consecutive series of diabetic patients hospitalized for CLI
between January 1999 and December 2003.
Results. PTA was successful performed in 993 patients. Seventeen (1.7%) major amputations were carried out. One death
and 33 non-fatal complications were observed. Mean follow-up was 26G15 months. Clinical restenosis was observed in 87
patients. The 5 years primary patency was 88%, 95% CI 86–91%. During follow-up 119 (12.0%) patients died at a rate of
6.7% per year.
Conclusions. PTA as the first choice revascularisation procedure is feasible, safe and effective for limb salvage in a high
percentage of diabetic patients. Clinical restenosis was an infrequent event and PTA could successfully be repeated in most
cases.Keywords: Diabetic foot; Critical limb ischemia; Peripheral occlusive disease; Peripheral angioplasty; Clinical restenosis;
Limb salvage; Survival.Successful revascularisation reduces the major ampu-
tation rate in diabetic patients presenting with critical
limb ischemia (CLI).1 The effectiveness of peripheral
bypass grafts (BP)2 and percutaneous transluminal
angioplasty (PTA)3 in achieving limb salvage has been
established.4,5 Nonetheless in recent publications
scepticism is still expressed concerning the feasibility,
effectiveness and long-term results of PTA, particu-
larly in the treatment of infrapopliteal disease.6,7 This
is probably due to the absence of large-scale trials ining author. Dr Faglia E., MD, Department of Internal
iabetology Centre, Diabetic Foot Centre, Policlinico
, Via Milanese 300, 20099 Sesto San Giovanni, Milano,
: ezio.faglia@multimedica.it
www.ilpiedediabetico.it
0620+ 08 $35.00/0 q 2005 Elsevier Ltd. All rights reserthe literature.8 In comparison to BP few reports have
evaluated the long-term results of PTA.9,10
In our protocol for the treatment of diabetic patients
with TransAtlantic Inter-Society Consensus (TASC)
criteria of CLI,11 PTA is the first choice revascularisation
procedure. PTA has a number of advantages: it does not
require general or spinal anaesthesia, mortality is very
low, complications are infrequent and a failed PTA
attempt does not preclude a subsequent by-pass graft.12
The aim of this study was to evaluate the effectiveness
and the limits ofPTAas thefirst-choice revascularisation
procedure in a consecutive population of diabetic
patients with CLI, with or without foot ulcer, hospital-
ised from January 1999 through December 2003 and
followed until June 2004.Eur J Vasc Endovasc Surg 29, 620–627 (2005)
doi:10.1016/j.ejvs.2005.02.035, available online at http://www.sciencedirect.com onved.
PTA in Ischemic Diabetic Foot 621Materials and MethodsProtocol
All diabetic subjects referred to our two foot centres
with foot ulcer or rest pain, were evaluated for the
presence of pedal pulses and transcutaneous oxygen
tension (TcPO2) values. The posterior tibial and
dorsalis pedis pulses were evaluated by palpation
and a Doppler continuous wave technique. TcPO2 was
evaluated on the dorsum of the foot. In cases with
reduced or absent foot pulses and TcPO2!50 mmHg,
duplex scanning was performed. If haemodinamically
significant stenoses were demonstrated during duplex
scanning, arteriography was carried out and a PTA
performed concomitantly, when possible. Fig. 1 shows
the protocol flow-chart.PTA procedure
PTA was indicated for angiographically documented
stenoses O50% of the vessel diameter.13 Stenoses and
occlusions greater than 10 cm in length, consecutive
multiple stenoses and also calcified occlusions were
treated by PTA. Vessel recanalization was considered
successful when direct flow was obtained in the
treated vessel, with no significant residual stenosis
along the whole artery. Fig. 2 shows an example of
multiple stenoses successfully treated. In the absence
of complications hospital stay for a PTA was 3 days.
The procedure was performed under local anaesthesia
through an antegrade puncture of the ipsilateral
common femoral artery. If obstructions were present
at duplex scanning in the iliac or common femoral
artery, the puncture was performed by means of a
contralateral approach. Rarely an open approach was
performed, when the puncture in the inguinal area
was difficult because of previous complicated surgery.Fig. 1. Flow-chart of diagnoA five or six French gauge sheath was positioned to
perform a preliminary angiographic study using
diluted (50%) non-ionic contrast medium.14 A 0.014–
0.035 in. guide wire and a 3.0–5.0 French balloon
catheter were used for the dilatation of 2–8 mm
diameter arteries. We tried to avoid the use of stents
especially in the infra popliteal arteries since the risk of
thrombosis is very high in such low-flow vessels.
Stents were employed if dissection or suboptimal
results occurred. During the procedure, 5000–7000 IU
of sodium heparin were infused into the arterial
lumen. If vessel spasm occurred, 0.1–0.2 mg of
nitroglycerine was infused as an intra-arterial bolus.
Intra-arterial thrombus was managed by catheter
aspiration and/or urokinase and heparin infusion.15
A nephroprotection protocol was used in all non-
dialyzed patients: 1500 ml saline was infused the day
before and the day after the procedure. In subjects
with creatinine O110 mg/dl, dopamine 2g/Kg/min
was infused 24 h before and after the procedure. In
patients with an ejection fraction !40%, 20 mg of
furosemide were injected intravenously at the begin-
ning and the end of the daily hydration. Creatinine
value was determined the day before and after the
PTA. All the patients were prescribed either ticlopi-
dine 500 mg/day or clopidogrel 75 mg/day for 30
days and subsequently acetyl salicylic acid
100 mg/day or ticlopidine 250 mg/day indefinitely.Complications
Any event that required specific medical or surgical
treatment or prolonged hospital stay following PTA
was recorded and considered a complication.
Haematoma formation at the puncture site was
considered as a not significant side effect unless
necessitating either surgery and/or packed red
blood cell transfusion.stic-therapeutic protocol.
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Fig. 2. PTA performed down to the foot in posterior tibial artery with multiple stenoses and occlusions.
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After PTA symptomatic outcome was evaluated and
TcPO2 values were reassessed 3–6 days after the
procedure.16 In patients presenting with rest pain
without foot ulcer, the disappearance of pain was
considered limb salvage successful. In patients with
foot ulcers we considered limb salvage successful
when the rest pain, if formerly present, disappeared
and the plantar stand was maintained, even when
achieved by a tarsal-metatarsal amputation.17 Any
above-the-ankle amputation, including the Syme
amputation, was considered a failure.Follow-up
After hospital discharge all the patients with foot ulcer
were examined at our centres until complete ulcer
healing occurred. All healed patients were provided
with extra-deep rocker shoes with soft leather and
customized insoles. Many patients were referred to
our centres from other hospitals and once healed, they
were discharged to their diabetes centres with theEur J Vasc Endovasc Surg Vol 29, June 2005strict instructions to perform an immediate evaluation
in case of ulcer or pain recurrence. Restenosis was
assessed clinically based on pain or ulcer reappear-
ance. In these situations TcPO2 was reassessed and
duplex scanning was performed.18 If TcPO2 was
significantly worse (!15% of the post-PTA value)
and duplex scanning was positive, the patient under-
went a repeat angiographic evaluation and a further
PTA, if possible. Asymptomatic restenosis (significant
stenoses at duplex scanning without pain or ulcer
worsening or recurrence) was not investigated. Clini-
cal restenosis, new vascular procedures, new amputa-
tions and date of death were recorded. All the data
regarding patients who were not followed directly by
our centres were obtained from the colleagues treating
these patients.Statistical methods
Descriptive statistics are reported as average values
and standard deviation for continuous variables and
as percentages and contingency tables for the quali-
tative and discrete variables. The 66 months primary
PTA in Ischemic Diabetic Foot 623patency has been estimated by the Kaplan–Meier
approach with 95% confidence intervals. The same
method has been used for the evaluation of time
elapsed from the date of PTA to the date of death. The
Stata 8.0 software package (Statistics/Data Analysis,
Stata Corporation, 4905 Lakeway Drive, College
Station, TX 77845, USA, 800-STATA-PC) was used.ResultsStudy population
Between June 1st 1999 and December 31st 2003, 1909
consecutive diabetic patients were hospitalised for
foot ulcer or ischemic rest pain in our two diabetic foot
centres. In 1191 patients at least one pedal pulse was
reduced or absent, the transcutaneous oxygen tension
was !50 mmHg and duplex scanning demonstrated
stenoses O50% of vessel diameter. All these patients
were referred for an angiographic study and, when-
ever possible, a concomitant PTA procedure. At
angiography, three patients had no angiographic
evidence of stenoses O50% of the vessel diameter.Table 1. Demographic and clinical characteristics of the PTA treated
Age (years)
Males (N)
Mean male age (years)
Females (N)
Mean female age (years)
Diabetes therapy (N)
Insulin therapy
Oral agents
Diet only
Diabetes duration (years)
Coronary artery disease (history) (N)
Anti-hypertensive therapy (N)
Retinopathy (history) (N)
Vibration perception threshold measured by biothesiometer O25 v (N)
Insensitivity inO5/9 areas using Semmes–Weinstein filament 10 g (N
Absence of Achilles’ tendon reflex (N)
Renal function (N)
Creatinine value%110 mg/dl
Creatinine valueO110 mg/dl
Dialysis
Smoking habit (N)
Non-smokers
Current smokers
Ex smokers
Infected ulcer (N)
Texas wound classification
0 c
I c
I d
II c
II d
III c
III d
Data are N (%) or meanG1 SD.These three patients were excluded from the analysis,
leaving 1188 with CLI.PTA as first-choice revascularisation procedure
PTAwas performed in 993 patients (83.6%) and in the
remaining 195 (16.4%) was not feasible due the
complete calcified occlusion of the vessel which did
not permit balloon catheter passage. Table 1 report the
demographic and clinical characteristics of the PTA
treated patients. Obstructions of O50% of vessel
diameter were located in the iliac/femoral/popliteal
axis in 67 patients (6.7%), exclusively in the infra-
popliteal axis in 316 patients (31.8%) and in both
femoral-popliteal and infrapopliteal axis in 610
patients (61.4%). Table 2 reports the number and
length of stenoses and occlusions. Of 993 patients
treated with PTA, 983 obtained at least one open artery
down to the foot: Fig. 3 shows the number of patients
with obstructions in the infrapopliteal arteries before
and after PTA.
Four hundred and five patients had a creatinine
value %110 mg/dl: creatinine value before the pro-
cedure was 1.08G0.20 mg/dl, and after the procedure
1.07G0.33 mg/dl (pZ0.707). Five hundred and fortypatients (NZ993)
69.5G9.4 –
663 (66.8%)
67.8G9.0 –
330 (33.2%)
72.9G9.3
620 (62.4%)
323 (32.5%)
50 (5.0%)
18.1G11.4 –
616 (62.0%)
715 (72.0%)
402 (40.5%)
777 (78.2%)
) 776 (77.1%)
891 (89.7%)
405 (40.8%)
540 (54.4%)
48 (4.8%)
453 (45.6%)
133 (13.4%)
407 (41.0%)
697 (70.2%)
125 (11.9%)
83 (8.4%)
73 (7.4%)
56 (5.6%)
132 (13.4%)
32 (3.2%)
492 (49.5%)
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Table 2. Stenoses (number of,O4 cm of length ormultiple) and occlusions (number of,O2 cm of length or multiple) in every artery of the
ischemic limb and number of successful PTA procedures performed
Artery Stenoses Multiple or
lengthO4 cm
Successful PTA Occlusions Multiple or
lengthO2 cm
Successful PTA
Iliac trunk 65 29 (44.6%) 65 (100%) 6 3 (50.0%) 6 (100%)
Profunda femoral 31 16 (51.6%) 25 (80.6%) 6 1 (16.7%) 5 (83.3%)
Superficial femoral 343 266 (77.6%) 341 (99.4%) 185 123 (66.5%) 142 (76.8%)
Popliteal 221 92 (41.6%) 215 (97.3%) 86 47 (54.7%) 77 (89.5%)
Anterior tibial 235 188 (80.0%) 215 (91.5%) 589 530 (90.0%) 142 (24.1%)
Posterior tibial 218 164 (75.2) 185 (84.7%) 725 679 (93.7%) 83 (11.4%)
Peroneal 337 241 (71.5%) 284 (84.3%) 342 257 (75.1%) 88 (25.7%)
E. Faglia et al.624subjects had a creatinineO110 mg/dl: creatinine value
before the procedure was 1.99G0.56 mg/dl, and after
procedure 1.81G0.49 mg/dl (p!0.001). Only one
patient had a creatinine increase O20% of the basal
value and required a prolonged hospital stay for
medical therapy. Five hundred and thirty-two patients
received supplemental furosemide since their cardiac
ejection fraction was less than 40%. TcPO2 increased
from 17.0G11.9 to 44.8G13.0 mmHg. The distribution
by class of TcPO2 values before and after PTA is
reported in Fig. 4.PTA complications
Thirty-four (3.4%) complications occurred. One sub-
ject died suddenly the night following PTA. One
patient underwent an above the knee amputation due
to acute distal thrombosis not suitable for surgical
revascularisation. Thirty-two complications required a
specific therapy or a prolonged hospital stay. Table 3
reports the complications in the PTA group.Limb salvage
Seventeen (1.7%) major amputations were carried out:
three were above the knee, 13 below the knee and oneFig. 3. Number of patients with obstructions in the
infrapopliteal arteries before and after PTA (NZ993).
Eur J Vasc Endovasc Surg Vol 29, June 2005was a Syme amputation. Minor amputations were
carried out in 478 patients: toe amputation in 55 (6.0%),
ray amputation in 232 (23.4%) and tarsal-metatarsal
amputation in 191 (19.2%). Surgical care without
amputation (bone subtraction, ulcerectomy, skin trans-
plantation) was performed in 171 (17.2%) patients.
Local care with dressing was sufficient to heal 202
(20.3%) patients. In all patients with rest pain the pain
disappeared. On June 30 2004 the ulcer had healed in
all but six patients.Follow-up
Nine hundred and seventy-one (97.8%) patients were
followed-up in the period from January 1st 1999 to June
30 2004. Follow-up information was not available for 22
(2.2%) patients. The mean follow-up was 26.2G15.1
months, range 6.6–66 months, median 22.9 months.
We observed 112 (11.3%) episodes of clinical rest-
enosis in 87 (8.8%) patients. One episode occurred in
72 patients, two episodes in nine patients, three
episodes in three patients, four episodes in two
patients, five episodes in one patient. The Kaplan–
Meier estimate of first episode of clinical restenosis
was 2.2% per year. The primary patency at 5 years was
88%, 95% confidence interval 86–91%. Fig. 5 shows theFig. 4. TcPO2 values distribution by 10 mmHg classes before
(NZ993) and after (NZ937) PTA in study population.
Table 3. Complications and their treatment in the PTA group
patients (NZ993)
Complication N Treatment
Sudden death following
PTA
1 –
Myocardial infarction 2 Intensive care unit
Angina 2 Medical treatment
Cardiac arrhythmia 1 Intensive care unit
Chest pain 1 Investigation, no treatment
Left ventricular failure 1 Medical treatment
Acute renal failure 1 Medical treatment without
dialysis
Haematoma 3 Transfusion
1 Investigation, no treatment
Access site
pseudoaneurysms
5 Surgical treatment
3 Surgical treatment plus
transfusion
Distal thrombosis 7 Thrombolysis effectiveness
3 By-pass graft
1 Above the knee amputation
Cholesterol embolism 1 Medical therapy
Fig. 6. Kaplan–Meier curve of survival.
PTA in Ischemic Diabetic Foot 625Kaplan–Meier curve of first episode of clinical rest-
enosis. Of the 87 patients in which clinical restenosis
occurred, PTA procedures were successful repeated in
70 (80.5%) patients. In the remaining 17 patients
(19.5%) a further PTA was not feasible. Out of the
971 followed patients, 119 (12.0%) died. The Kaplan–
Meier estimate of death was 6.7% per year, 5 year
survival 74%, confidence interval 66–80%. Fig. 6 shows
the Kaplan–Meier survival curve. During the follow-
up six patients who had a PTA at our centres and a
healed ulcer underwent subsequent procedures in
another institution: one PTA, one BP, two above and
two below the knee amputations.Discussion
The aim of the revascularisation procedure is ‘to
provide sufficient blood flow to relieve rest pain and
heal skin lesions’. The ideal revascularisationFig. 5. Kaplan–Meier curve of clinical restenosis.procedure is the one that ‘avoids a general anaesthesia,
poses a lesser systemic stress, and has fewer serious
complications’. We totally agree with these Trans-
Atlantic Inter-Society Consensus (TASC)
affirmations.11
In diabetic patients occlusive peripheral disease is
characterised by distal, multiple obstructions with a
higher percentage of occlusions with respect to
stenoses.19 These data are confirmed in our study
population. The most common morphological charac-
teristics of the occlusive disease in our population
corresponds to the type C and D of the TASC
recommendation 93. In a previous publication20 we
demonstrated that PTA was feasible for the treatment
of long, multiple and calcified stenoses and occlusions.
The main obstacle to recanalization is the complete
calcified occlusion of the vessel, which does not permit
balloon catheter passage. This obstacle is absolutely
independent of both the length and the number of
obstructions in the artery. This study confirms the
above described results on a larger patient population.
Our protocol employs a PTA revascularisation attempt
irrespective of the length, the number and the
localisation of obstructions. This protocol let us obtain
a high number of technical successes and a high limb
salvage rate. This is especially true considering that
PTAwas able to recanalize at least one vessel down to
the foot in 477 of the 487 patients who did not even
have a single patent leg artery down to the foot. These
results were obtained employing a procedure with low
morbidity and mortality rate, which does not need
either general or spinal anaesthesia, does not cause
skin lesions and necessitates only a short hospital stay.
The feasibility is very high considering that this
procedure is consecutively performed in our whole
population and not in selected patients with ‘a priori’
high success probabilities. Based on these results, we
find the TASC recommendation 35 for the revascular-
isation technique of choice to be restrictive and believeEur J Vasc Endovasc Surg Vol 29, June 2005
E. Faglia et al.626it is useful to attempt an endoluminal revascularisa-
tion in whatever type of stenosis or occlusion. We
prefer to perform an open surgical revascularisation
when endoluminal revascularisation is not possible or
insufficient.
We observed a single death which occurred the
night following PTA in a cardiopathic patient.21
Sudden death is particularly frequent in cardiopathic
diabetic patients.22 We also observed one patient with
massive distal thrombosis: in this patient thrombolysis
was ineffective, surgical revascularisation was con-
sidered unsuitable and a major amputation was
carried out. All the other complications were resolved
without major amputation. These data confirm that the
side effects of PTA are very low and mortality is
minimal,23,24 especially considering a study popu-
lation such as ours in which the mean age was 70
years, with more than 60% being cardiopathic and
many having renal insufficiency and hypertension.
In our protocol the angiographic study and PTA
were performed in the same session. This approach
reduces both patient stress and the amount of contrast
administered, which are particularly relevant in
subjects with cardiac or renal insufficiency.25 The
combination of a high technical success rate, a low
complications rate and a high limb salvage rate are
possible if the PTA physician is particularly skilled
and patient care is performed by means of a skilled
combined medical and surgical team.26 PTA is thought
by some operators to be of limited efficacy because of
its supposedly high restenosis rate. The clinical rest-
enosis rate in our series was low, and moreover, the
restenosis was successfully manageable by a second
PTA in many patients. The morphological restenosis is
probably higher. Nevertheless, when tissue healing
has occurred and no pain is present we consider a
delayed closure of the recanalized vessel as clinically
irrelevant.27
The diagnostic and therapeutic protocol applied at
our centre has not changed during the study period.
We do not record ankle-brachial pressure index (ABI)
due to the high percentage of patients with arterial
calcification.28 In our previous paper20 ABI determi-
nation was not possible in 32.5% of patients. In this
study population, among the first 200 patients enrolled
this percentage was 41.8% and, therefore, we decided
to abandon the registration of this index in the data-
base. In our usual patient care the index is employed
when possible and when it is impossible, pulses are
acoustically searched for using continuous wave
Doppler.
In conclusion, PTA is the first choice for revascular-
isation in diabetic ischemic foot. PTA is feasible in
most patients, complications are infrequent andEur J Vasc Endovasc Surg Vol 29, June 2005mortality is very low. Clinical restenosis was an
infrequent finding and the procedure could success-
fully be repeated in most cases.References
1 LoGerfo FW, Gibbons GW, Pomposelli Jr FB, Campbell DR,
Miller A, Freeman DV et al. Trends in the care of the diabetic
foot. Expanded role of arterial reconstruction. Arch Surg 1992;
127:617–620.
2 Pomposelli Jr FB, Marcaccio EJ, Gibbons GW, Campbell DR,
Freeman DV, Burgess AM et al. Dorsalis pedis arterial bypass:
durable limb salvage for foot ischemia in patients with diabetes
mellitus. J Vasc Surg 1995;21:375–384.
3 Soder HK, Manninen HI, Jaakkola P, Matsi PJ, Rasanen HT,
Kaukanen E et al. Prospective trial of infrapopliteal artery
balloon angioplasty for critical limb ischemia: angiographyc and
clinical results. J Vasc Interv Radiol 2000;11:1021–1031.
4 Lang GC, Davis M, Baker D. Bypass surgery for chronic lower
limb ischemia. Cochane Libr 2001;4:1–16.
5 Al-Omran M, Tu JV, Johnston KW, MamdaniMM, Kucey DS.
Outcome of revascularization procedures for peripheral arterial
occlusive disease in Ontario between 1991 and 1998: a popu-
lation-based study. J Vasc Surg 2003;38:279–288.
6 Ouriel K. Peripheral arterial disease. Lancet 2001;358:1257–1264.
7 American Diabetes Association. Peripheral arterial disease in
people with diabetes. Diabetes Care 2003;12:333–341.
8 Fraser SC, al-KutoubiMA,Wolfe JH. Percutaneous translum-
inal angioplasty of the infrapopliteal vessels: the evidence.
Radiology 1996;200:33–36.
9 Dorros G, Jaff MR, Dorros AM, Mathiak LM, He T.
Tibioperoneal (outflow lesion) angioplasty can be used as
primary treatment in 235 patients with critical limb ischemia:
five years follow-up. Circulation 2001;104:2057–2062.
10 Pomposelli FB, Campbell DR. Vascular surgery for the diabetic
foot. In: Veves A, Giurini JM, LoGerfo FW, eds. The diabetic foot.
Totowa, NJ, USA: Humana Press, 2002:411–428.
11 TASC TransAtlantic Inter-Society Consensus (TASC). Manage-
ment of peripheral arterial disease (PAD). Eur J Vasc Endovasc
Surg 2000;19(Suppl A):208–290.
12 Faglia E, Favales F, Quarantiello A, Calia P, Brambilla G,
Rampoldi A et al. Feasibility and effectiveness of peripheral
percutaneous transluminal angioplasty in diabetic subjects with
foot ulcers. Diabetes Care 1996;19:1261–1264.
13 Pentecost MJ, Criqui MH, Dorros G, Goldstone J,
Johnston KW, Martin EC et al. Guidelines for peripheral
percutaneous transluminal angioplasty of the abdominal aorta
and lower extremity vessels. A statement for health professionals
from a special writing group of the councils on cardiovascular
radiology, arteriosclerosis, cardio-thoracic and vascular surgery,
clinical cardiology, and epidemiology and prevention, the
American Heart Association. Circulation 1994;89:511–531.
14 Gates J, Hartnell GG. Optimized diagnostic angiography in
high-risk patients with severe peripheral vascular disease.
Radiographics 2000;20:121–133.
15 Papavassiliou VG, Walker SR, Bolia A, Fishwick G,
London N. Techniques for the endovascular management of
complications following lower limb percutaneous transluminal
angioplasty. Eur J Vasc Endovasc Surg 2003;25:125–130.
16 Bunt TJ, Hollowey GA. TcPO2 as an accurate predictor of
therapy in limb salvage. Ann Vasc Surg 1996;10:227–237.
17 Garbalosa JC, Cavanagh PR, Wu G, Ulbrecht JS, Becker MB,
Alexander IJ. Foot function in diabetic patients after partial
amputation. Foot Ankle Int 1996;17:43–48.
18 Grollman J, LevinDC, BettmannMA,GomesAS,Henkin RE,
Hessel SJ et al. Recurrent symptoms following lower extremity
angioplasty: claudication and threatened limb. American College
PTA in Ischemic Diabetic Foot 627of Radiology. ACR appropriateness criteria. Radiology 2000;
215(Suppl):95–99.
19 Jude EB, Oyibo SO, Chalmers N, Boulton AJ. Peripheral
arterial disease in diabetic and nondiabetic patients. A compari-
son of severity and outcome. Diabetes Care 2001;24:1433–1437.
20 Faglia E,ManteroM, CaminitiM, Caravaggi C, De Giglio R,
Pritelli C et al. Extensive use of peripheral angioplasty,
especially infrapopliteal, in the treatment of ischemic foot ulcer:
clinical results of a multicentric study of 221 consecutive diabetic
subjects. J Intern Med 2002;252:225–232.
21 Barzilay JI, Kronmal RA, Bittner V, Eaker E, Evans C,
Foster ED. Coronary artery disease in diabetic patients with
lower-extremity arterial disease: disease characteristics and
survival. Diabetes Care 1997;20:1381–1387.
22 Stevens MJ, Raffel DM, Allman KC, Dayanikli F, Ficaro E,
Sandford T et al. Cardiac sympathetic dysinnervation in
diabetes: implications for enhanced cardiovascular risk. Circula-
tion 1998;98:961–968.
23 Kumpe DA, Rutherford RB. Percutaneous transluminal angio-
plasty for lower extremity ischemia. In: Rutheford RB, ed.
Vascular surgery. 3rd ed Philadelphia, PA, USA: WB Saunders,
1992:759–761.24 London NJ, Varty K, Sayers RD, Thompson MM, Bell PR,
Bolia A. Percutaneous transluminal angioplasty for lower-limb
critical ischemia. Br J Surg 1995;82:1232–1235.
25 Parfrey PS, Griffiths SM, Barrett BJ, Paul MD, Genge M,
Withers J et al. Contrast material-induced renal failure in
patients with diabetes mellitus, renal insufficiency, or both. N
Engl J Med 1989;320:143–149.
26 Holstein PE, Sørensen S. Limb salvage experience in a
multidisciplinary diabetic foot unit. Diabetes Care 1999;22(Suppl
2):B97–B103.
27 Isner JM, Rosenfield K. Redefining the treatment of peripheral
artery disease. Role of percutaneous revascularization. Circula-
tion 1993;88:1534–1557.
28 EmanueleMA, Bauchanan BJ,AbrairaC. Elevated leg systolic
pressure and arterial calcifications in diabetic occlusive vascular
disease. Diabetes Care 1981;4:289–292.
Accepted 21 February 2005
Available online 28 March 2005Eur J Vasc Endovasc Surg Vol 29, June 2005
